1. Home
  2. DNUT vs CADL Comparison

DNUT vs CADL Comparison

Compare DNUT & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krispy Kreme Inc.

DNUT

Krispy Kreme Inc.

HOLD

Current Price

$3.24

Market Cap

598.2M

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$9.89

Market Cap

694.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNUT
CADL
Founded
1937
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
598.2M
694.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
DNUT
CADL
Price
$3.24
$9.89
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$4.15
$19.00
AVG Volume (30 Days)
2.7M
1.4M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
$1,522,616,000.00
$125,000.00
Revenue This Year
$0.55
N/A
Revenue Next Year
$3.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.88
$4.35
52 Week High
$5.11
$11.36

Technical Indicators

Market Signals
Indicator
DNUT
CADL
Relative Strength Index (RSI) 41.48 52.90
Support Level $3.18 $9.19
Resistance Level $3.74 $10.59
Average True Range (ATR) 0.12 0.56
MACD -0.02 -0.07
Stochastic Oscillator 27.27 41.14

Price Performance

Historical Comparison
DNUT
CADL

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: